| Literature DB >> 32734026 |
Zachery Ryan Jarrell1, Muslah Uddin Ahammad1, Andrew Parks Benson1.
Abstract
The adoption of genetically engineered (GE) crops in agriculture has increased dramatically over the last few decades. Among the transgenic plants, those tolerant to the herbicide glyphosate are among the most common. Weed resistance to glyphosate-based herbicides (GBHs) has been on the rise, leading to increased herbicide applications. This, in turn, has led to increased glyphosate residues in feed. Although glyphosate has been considered to be generally safe to animal health, recent studies have shown that GBHs have potential to cause adverse effects in animal reproduction, including disruption of key regulatory enzymes in androgen synthesis, alteration of serum levels of estrogen and testosterone, damage to reproductive tissues and impairment of gametogenesis. This review emphasizes known effects of GBHs on reproductive health as well as the potential risk GBH residues pose to animal agriculture.Entities:
Keywords: Animal; Glyphosate; Herbicide; Reproduction; Residue
Year: 2020 PMID: 32734026 PMCID: PMC7386766 DOI: 10.1016/j.vas.2020.100126
Source DB: PubMed Journal: Vet Anim Sci ISSN: 2451-943X
Effects of glyphosate-based herbicides and their ingredients on the reproductive health of females across species at varying dosages. Dosages listed are the minimum reported dosage to cause an effect. In cases where both in vitro and in vivo treatments have been investigated, the in vivo treatment was represented. ↑ represents an increase in the listed effect, while ↓ represents a decrease. The minimum effect-causing dosage and format of treatment are indicated by a number followed by a two-letter abbreviation of the treatment. In the case of oral gavage (OG), subcutaneous injection (SC) and in ovo (IO) treatment, the treatment was reported as mg/kg. For in vitro (IT), aquatic exposure (AQ) and topical application on the surface of the egg (TA), the reported level is reported as ppm. The letter given in italics corresponds to the chemical treatment investigated: a commercial GBH formulation (H), glyphosate (G) or POEA (P). Corresponding studies are indicated by the lower-case letter (a-n) on the right of each cell.
| ↓ 2000 IT | a | |||||||||||||
| ↓ 0.5 IT | b | |||||||||||||
| ↑ 50 OG | c | |||||||||||||
| ↓ 5 IT | d | ↑ 50 OG | c | |||||||||||
| ↓ 10 IT | e | |||||||||||||
| ↓ 10 IT | e | ↑ 50 OG | c | |||||||||||
| ↑ 50 OG | c | |||||||||||||
| ↑ 0.01 IT | f | |||||||||||||
| ↑ 2 SC | g,h | ↑ 2 SC | i | |||||||||||
| ↓ 0.1 IT | d,e | |||||||||||||
| ↓ 10 AQ | j | ↓ 126 OG | k | |||||||||||
| ↓ 10 IT | l | |||||||||||||
| ↑ 9.9 IO | m | |||||||||||||
| ↑ 10 AQ | j | ↑ 11206 TA | n | ↑ 9.9 IO | m | |||||||||
aRichard et al., 2005. bGasnier et al., 2009. cRomano et al., 2012. dPerego et al., 2016. ePerego et al., 2017. fWrobel, 2018. gIngaramo et al., 2016.
hVarayoud et al., 2017. iSchimpf et al., 2017. jWebster et al., 2014. kHamdaoui et al., 2018. lDefarge et al., 2016. mWinnick, 2013. nSparling et al., 2006.
Effects of glyphosate-based herbicides and their ingredients on the reproductive health of males across species at varying dosages. Dosages listed are the minimum reported dosage to cause an effect. In cases where both in vitro and in vivo treatment has been investigated, the in vivo treatment was represented. represents an increase in the listed effect, while ¯ represents a decrease. Represents both a reported increase and a reported decrease at the given level of treatment, and “no” represents no observed effect. The minimum effect-causing dosage and format of treatment are indicated by a number followed by a two-letter abbreviation of the treatment format. In the case of oral gavage (OG), prenatal oral gavage (PG), subcutaneous injection (SC) and in ovo (IO) treatment, the treatment was reported as mg/kg. For in vitro (IT) and aquatic exposure (AQ) the reported level is reported as ppm. The letter given in italics corresponds to the chemical treatment investigated: a commercial GBH formulation (H), glyphosate (G) or POEA (P). A “/” between any of these treatment abbreviations indicates that both treatments listed resulted in an effect at the indicated level.
| Zebrafish | Duck | Rat | Albino rat | Wistar rat | SD rat | Mouse | Human | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aromatase activity | ↑ 1 IT | a | ↓ 10 IT | b | ||||||||||||
| Androgen receptors | ↓ 5 OG | c | ||||||||||||||
| Androgen levels | ↓ 5 OG | c | 10 OG | d,e | ↓ 3.6 OG | f | ↓ 5 OG | g-i | ↓ 1 IT | j,k | ||||||
| Estrogen receptors | ↓ 2 IT | b | ||||||||||||||
| Estrogen levels | ↓ 5 OG | c | ↑ 50 OG | d | ||||||||||||
| Progesterone levels | ↓ 25 IT | l | ||||||||||||||
| FSH activity | ↑ 50 OG | d | ↓ 3.6 OG | f | ||||||||||||
| LH activity | ↑ 50 OG | d | ↓ 3.6 OG | f | ||||||||||||
| Prolactin levels | ↓ 3.6 OG | f | ||||||||||||||
| Testicular abnormalities | ↑ 5 OG | c | ↑ 50 OG | d,m | ↓ 3.6 OG | f | ↑ 5 OG | g,h | no 25 OG | k | ||||||
| Epididymal abnormalities | ↑ 5 OG | c | ↑ 5 OG | i | ||||||||||||
| Sertoli cell death | ↑ 1000 IT | j | ↑ 500 IT | n | ||||||||||||
| Leydig cell death | ↑ 250 OG | m | ↓ 3.6 OG | f | ↑ 1000 IT | j | ||||||||||
| Germ cell death | ↑ 1000 IT | j | ||||||||||||||
| Sperm count | ↓ 250 OG | m | ↓ 3.6 OG | f | ↓ 5 OG | g,i | ||||||||||
| Teratospermia | ↓ 3.6 OG | f | ↑ 50 PG | g | ||||||||||||
| Sperm viability | ↓ 250 OG | m | ↓ 5 OG | i | ||||||||||||
| Sperm DNA integrity | ↓ 5 AQ | o | ||||||||||||||
| Sperm motility | ↓ 5 AQ | o | ↓ 250 OG | m | ↓ 3.6 OG | f | ↓ 5 OG | i | ↓ 0.36 IT | p,q | ||||||
| Mitochondrial function | ↓ 5 AQ | o | ↓ 0.36 IT | p,q | ||||||||||||
aClair et al., 2012. bGasnier et al., 2009. cOliveira et al., 2006. dRomano et al., 2012. ePandey & Rudraiah, 2015. fOwagboriaye et al., 2017. gDallegrave et al., 2007. hRomano et al., 2010. iAbarikwu et al., 2015. jClair et al., 2012. kJohansson et al., 2018. lWalsh et al., 2000. mIkpeme et al., 2012. nVanlaeys et al., 2018.
oLopes et al., 2014. p Anifandis et al., 2017. qAnifandis et al., 2017.
Corresponding studies are indicated by the lower-case letter (a-q) on the right of each cell.